HEADER TRANSCRIPTION, TRANSFERASE 11-APR-08 3CTB TITLE TETHERED PXR-LBD/SRC-1P APOPROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PREGNANE X RECEPTOR, LINKER, STEROID RECEPTOR COACTIVATOR COMPND 3 1; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: PXR, RESIDUES 130-434, LINKER, SRC-1, RESIDUES 678-700; COMPND 6 SYNONYM: NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2, ORPHAN COMPND 7 NUCLEAR RECEPTOR PXR, ORPHAN NUCLEAR RECEPTOR PAR1, STEROID AND COMPND 8 XENOBIOTIC RECEPTOR, SXR, NCOA-1, STEROID RECEPTOR COACTIVATOR 1, COMPND 9 SRC-1, RIP160, PROTEIN HIN-2, RENAL CARCINOMA ANTIGEN NY-REN-52; COMPND 10 EC: 2.3.1.48; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1I2, PXR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 OTHER_DETAILS: THE PEPTIDE FROM STEROID RECEPTOR COACTIVATOR 1 WAS SOURCE 9 CHEMICALLY SYNTHESIZED. THE SEQUENCE OF THE PEPTIDE IS NATURALLY SOURCE 10 FOUND IN HOMO SAPIENS (HUMAN). KEYWDS PXR, SRC-1, TETHERED, ENGINEERED, DRUG-DRUG INTERACTIONS, DNA- KEYWDS 2 BINDING, METAL-BINDING, NUCLEUS, RECEPTOR, TRANSCRIPTION REGULATION, KEYWDS 3 ZINC-FINGER, TRANSCRIPTION, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.A.LESBURG REVDAT 4 30-AUG-23 3CTB 1 SEQADV REVDAT 3 16-AUG-17 3CTB 1 SOURCE REVDAT 2 02-APR-14 3CTB 1 SOURCE VERSN REVDAT 1 02-DEC-08 3CTB 0 JRNL AUTH W.WANG,W.W.PROSISE,J.CHEN,S.S.TAREMI,H.V.LE,V.MADISON,X.CUI, JRNL AUTH 2 A.THOMAS,K.C.CHENG,C.A.LESBURG JRNL TITL CONSTRUCTION AND CHARACTERIZATION OF A FULLY ACTIVE JRNL TITL 2 PXR/SRC-1 TETHERED PROTEIN WITH INCREASED STABILITY JRNL REF PROTEIN ENG.DES.SEL. V. 21 425 2008 JRNL REFN ISSN 1741-0126 JRNL PMID 18456871 JRNL DOI 10.1093/PROTEIN/GZN017 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 1.3.1 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 54169 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 2713 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.12 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.50 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 8424 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 22.020 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8014 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE : 0.2446 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.87 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 410 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4700 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 356 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 44.07 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 52.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.08797 REMARK 3 B22 (A**2) : -1.58122 REMARK 3 B33 (A**2) : -0.50675 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.256 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : NULL REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : NULL REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4824 ; 2.000 ; NULL REMARK 3 BOND ANGLES : 6467 ; 2.000 ; NULL REMARK 3 TORSION ANGLES : NULL ; NULL ; NULL REMARK 3 TRIGONAL CARBON PLANES : 117 ; 2.000 ; NULL REMARK 3 GENERAL PLANES : 685 ; 5.000 ; NULL REMARK 3 ISOTROPIC THERMAL FACTORS : 4824 ; 20.000 ; NULL REMARK 3 BAD NON-BONDED CONTACTS : 68 ; 5.000 ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : NULL ; NULL ; NULL REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : NULL ; NULL ; NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.15 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : NULL REMARK 3 OTHER TORSION ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CTB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047185. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-05 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MULTILAYER MIRRORS REMARK 200 OPTICS : VARIMAX HF REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS HTC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 54259 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 3.580 REMARK 200 R MERGE (I) : 0.03900 REMARK 200 R SYM (I) : 0.03900 REMARK 200 FOR THE DATA SET : 13.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.49 REMARK 200 R MERGE FOR SHELL (I) : 0.46100 REMARK 200 R SYM FOR SHELL (I) : 0.46100 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1NRL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-30% MPD OR ISOPROPANOL, 100 MM REMARK 280 IMIDAZOLE, PH 7, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 42.62000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 52.61500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 44.62000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 52.61500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 42.62000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 44.62000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1870 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 119 REMARK 465 LYS A 120 REMARK 465 LYS A 121 REMARK 465 GLY A 122 REMARK 465 HIS A 123 REMARK 465 HIS A 124 REMARK 465 HIS A 125 REMARK 465 HIS A 126 REMARK 465 HIS A 127 REMARK 465 HIS A 128 REMARK 465 GLY A 129 REMARK 465 SER A 130 REMARK 465 GLU A 131 REMARK 465 ARG A 132 REMARK 465 THR A 133 REMARK 465 GLY A 134 REMARK 465 THR A 135 REMARK 465 GLN A 136 REMARK 465 PRO A 137 REMARK 465 LEU A 138 REMARK 465 GLY A 139 REMARK 465 VAL A 140 REMARK 465 GLN A 141 REMARK 465 SER A 179 REMARK 465 SER A 180 REMARK 465 GLY A 181 REMARK 465 CYS A 182 REMARK 465 GLU A 183 REMARK 465 LEU A 184 REMARK 465 PRO A 185 REMARK 465 GLU A 186 REMARK 465 SER A 187 REMARK 465 LEU A 188 REMARK 465 GLN A 189 REMARK 465 ALA A 190 REMARK 465 PRO A 191 REMARK 465 ASP A 310 REMARK 465 THR A 311 REMARK 465 ALA A 312 REMARK 465 GLY A 313 REMARK 465 GLY A 314 REMARK 465 PHE A 315 REMARK 465 GLY A 433 REMARK 465 SER A 434 REMARK 465 GLY A 435 REMARK 465 GLY A 436 REMARK 465 SER A 437 REMARK 465 GLY A 438 REMARK 465 GLY A 439 REMARK 465 SER A 440 REMARK 465 SER A 441 REMARK 465 HIS A 442 REMARK 465 SER A 443 REMARK 465 GLY A 459 REMARK 465 SER A 460 REMARK 465 PRO A 461 REMARK 465 SER A 462 REMARK 465 MET B 119 REMARK 465 LYS B 120 REMARK 465 LYS B 121 REMARK 465 GLY B 122 REMARK 465 HIS B 123 REMARK 465 HIS B 124 REMARK 465 HIS B 125 REMARK 465 HIS B 126 REMARK 465 HIS B 127 REMARK 465 HIS B 128 REMARK 465 GLY B 129 REMARK 465 SER B 130 REMARK 465 GLU B 131 REMARK 465 ARG B 132 REMARK 465 THR B 133 REMARK 465 GLY B 134 REMARK 465 THR B 135 REMARK 465 GLN B 136 REMARK 465 PRO B 137 REMARK 465 LEU B 138 REMARK 465 GLY B 139 REMARK 465 VAL B 140 REMARK 465 GLN B 141 REMARK 465 SER B 179 REMARK 465 SER B 180 REMARK 465 GLY B 181 REMARK 465 CYS B 182 REMARK 465 GLU B 183 REMARK 465 LEU B 184 REMARK 465 PRO B 185 REMARK 465 GLU B 186 REMARK 465 SER B 187 REMARK 465 LEU B 188 REMARK 465 GLN B 189 REMARK 465 ALA B 190 REMARK 465 PRO B 191 REMARK 465 ASP B 310 REMARK 465 THR B 311 REMARK 465 ALA B 312 REMARK 465 GLY B 313 REMARK 465 GLY B 314 REMARK 465 PHE B 315 REMARK 465 GLN B 316 REMARK 465 THR B 432 REMARK 465 GLY B 433 REMARK 465 SER B 434 REMARK 465 GLY B 435 REMARK 465 GLY B 436 REMARK 465 SER B 437 REMARK 465 GLY B 438 REMARK 465 GLY B 439 REMARK 465 SER B 440 REMARK 465 SER B 441 REMARK 465 HIS B 442 REMARK 465 SER B 443 REMARK 465 PRO B 461 REMARK 465 SER B 462 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 490 O HOH B 549 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MET B 159 SD MET B 159 CE -0.425 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 159 CG - SD - CE ANGL. DEV. = -14.3 DEGREES REMARK 500 PRO A 384 C - N - CD ANGL. DEV. = -21.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 231 -132.39 -106.26 REMARK 500 LYS A 234 -28.82 -35.76 REMARK 500 PHE A 349 54.67 -93.20 REMARK 500 GLN A 383 -149.76 -42.58 REMARK 500 PRO A 384 -46.86 -5.08 REMARK 500 HIS A 418 84.87 -153.52 REMARK 500 PHE A 420 -17.88 -152.32 REMARK 500 HIS A 449 59.96 -141.40 REMARK 500 ARG B 193 176.27 -38.60 REMARK 500 GLU B 194 -0.79 60.81 REMARK 500 LYS B 234 -27.69 92.24 REMARK 500 CYS B 301 43.08 -108.12 REMARK 500 PHE B 349 59.08 -93.56 REMARK 500 ASN B 380 -2.98 -147.45 REMARK 500 HIS B 418 86.12 -160.20 REMARK 500 PHE B 420 -13.55 -152.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NRL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN PXR-LBD IN COMPLEX WITH AN SRC-1 REMARK 900 COACTIVATOR PEPTIDE AND SR12813 REMARK 900 RELATED ID: 1ILH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN PREGNANE X RECEPTOR LIGAND BINDING REMARK 900 DOMAIN BOUND TO SR12813 REMARK 900 RELATED ID: 1ILG RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF APO HUMAN PREGNANE X RECEPTOR LIGAND BINDING REMARK 900 DOMAIN REMARK 900 RELATED ID: 3CTC RELATED DB: PDB REMARK 900 TETHERED PXR-LBD/SRC-1P COMPLEXED WITH SR-1281 DBREF 3CTB A 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 3CTB A 440 462 UNP Q15788 NCOA1_HUMAN 678 700 DBREF 3CTB B 130 434 UNP O75469 NR1I2_HUMAN 130 434 DBREF 3CTB B 440 462 UNP Q15788 NCOA1_HUMAN 678 700 SEQADV 3CTB MET A 119 UNP O75469 EXPRESSION TAG SEQADV 3CTB LYS A 120 UNP O75469 EXPRESSION TAG SEQADV 3CTB LYS A 121 UNP O75469 EXPRESSION TAG SEQADV 3CTB GLY A 122 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS A 123 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS A 124 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS A 125 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS A 126 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS A 127 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS A 128 UNP O75469 EXPRESSION TAG SEQADV 3CTB GLY A 129 UNP O75469 EXPRESSION TAG SEQADV 3CTB GLY A 435 UNP O75469 LINKER SEQADV 3CTB GLY A 436 UNP O75469 LINKER SEQADV 3CTB SER A 437 UNP O75469 LINKER SEQADV 3CTB GLY A 438 UNP O75469 LINKER SEQADV 3CTB GLY A 439 UNP O75469 LINKER SEQADV 3CTB MET B 119 UNP O75469 EXPRESSION TAG SEQADV 3CTB LYS B 120 UNP O75469 EXPRESSION TAG SEQADV 3CTB LYS B 121 UNP O75469 EXPRESSION TAG SEQADV 3CTB GLY B 122 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS B 123 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS B 124 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS B 125 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS B 126 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS B 127 UNP O75469 EXPRESSION TAG SEQADV 3CTB HIS B 128 UNP O75469 EXPRESSION TAG SEQADV 3CTB GLY B 129 UNP O75469 EXPRESSION TAG SEQADV 3CTB GLY B 435 UNP O75469 LINKER SEQADV 3CTB GLY B 436 UNP O75469 LINKER SEQADV 3CTB SER B 437 UNP O75469 LINKER SEQADV 3CTB GLY B 438 UNP O75469 LINKER SEQADV 3CTB GLY B 439 UNP O75469 LINKER SEQRES 1 A 344 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 A 344 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 A 344 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 A 344 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 A 344 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 A 344 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 A 344 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 A 344 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 A 344 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 A 344 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 A 344 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 A 344 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 A 344 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 A 344 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 A 344 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 A 344 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 A 344 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 A 344 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 A 344 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 A 344 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 A 344 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 A 344 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 A 344 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 A 344 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 A 344 ILE THR GLY SER GLY GLY SER GLY GLY SER SER HIS SER SEQRES 26 A 344 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 27 A 344 GLN GLU GLY SER PRO SER SEQRES 1 B 344 MET LYS LYS GLY HIS HIS HIS HIS HIS HIS GLY SER GLU SEQRES 2 B 344 ARG THR GLY THR GLN PRO LEU GLY VAL GLN GLY LEU THR SEQRES 3 B 344 GLU GLU GLN ARG MET MET ILE ARG GLU LEU MET ASP ALA SEQRES 4 B 344 GLN MET LYS THR PHE ASP THR THR PHE SER HIS PHE LYS SEQRES 5 B 344 ASN PHE ARG LEU PRO GLY VAL LEU SER SER GLY CYS GLU SEQRES 6 B 344 LEU PRO GLU SER LEU GLN ALA PRO SER ARG GLU GLU ALA SEQRES 7 B 344 ALA LYS TRP SER GLN VAL ARG LYS ASP LEU CYS SER LEU SEQRES 8 B 344 LYS VAL SER LEU GLN LEU ARG GLY GLU ASP GLY SER VAL SEQRES 9 B 344 TRP ASN TYR LYS PRO PRO ALA ASP SER GLY GLY LYS GLU SEQRES 10 B 344 ILE PHE SER LEU LEU PRO HIS MET ALA ASP MET SER THR SEQRES 11 B 344 TYR MET PHE LYS GLY ILE ILE SER PHE ALA LYS VAL ILE SEQRES 12 B 344 SER TYR PHE ARG ASP LEU PRO ILE GLU ASP GLN ILE SER SEQRES 13 B 344 LEU LEU LYS GLY ALA ALA PHE GLU LEU CYS GLN LEU ARG SEQRES 14 B 344 PHE ASN THR VAL PHE ASN ALA GLU THR GLY THR TRP GLU SEQRES 15 B 344 CYS GLY ARG LEU SER TYR CYS LEU GLU ASP THR ALA GLY SEQRES 16 B 344 GLY PHE GLN GLN LEU LEU LEU GLU PRO MET LEU LYS PHE SEQRES 17 B 344 HIS TYR MET LEU LYS LYS LEU GLN LEU HIS GLU GLU GLU SEQRES 18 B 344 TYR VAL LEU MET GLN ALA ILE SER LEU PHE SER PRO ASP SEQRES 19 B 344 ARG PRO GLY VAL LEU GLN HIS ARG VAL VAL ASP GLN LEU SEQRES 20 B 344 GLN GLU GLN PHE ALA ILE THR LEU LYS SER TYR ILE GLU SEQRES 21 B 344 CYS ASN ARG PRO GLN PRO ALA HIS ARG PHE LEU PHE LEU SEQRES 22 B 344 LYS ILE MET ALA MET LEU THR GLU LEU ARG SER ILE ASN SEQRES 23 B 344 ALA GLN HIS THR GLN ARG LEU LEU ARG ILE GLN ASP ILE SEQRES 24 B 344 HIS PRO PHE ALA THR PRO LEU MET GLN GLU LEU PHE GLY SEQRES 25 B 344 ILE THR GLY SER GLY GLY SER GLY GLY SER SER HIS SER SEQRES 26 B 344 SER LEU THR GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU SEQRES 27 B 344 GLN GLU GLY SER PRO SER FORMUL 3 HOH *356(H2 O) HELIX 1 1 THR A 144 PHE A 162 1 19 HELIX 2 2 ARG A 193 SER A 208 1 16 HELIX 3 3 GLY A 233 SER A 238 5 6 HELIX 4 4 LEU A 239 ILE A 261 1 23 HELIX 5 5 ILE A 261 ASP A 266 1 6 HELIX 6 6 PRO A 268 THR A 290 1 23 HELIX 7 7 GLN A 317 LEU A 320 5 4 HELIX 8 8 GLU A 321 LEU A 333 1 13 HELIX 9 9 HIS A 336 PHE A 349 1 14 HELIX 10 10 GLN A 358 ARG A 381 1 24 HELIX 11 11 GLN A 383 ARG A 387 5 5 HELIX 12 12 PHE A 388 HIS A 418 1 31 HELIX 13 13 THR A 422 GLY A 430 1 9 HELIX 14 14 HIS A 449 GLU A 458 1 10 HELIX 15 15 THR B 144 PHE B 162 1 19 HELIX 16 16 ALA B 196 LEU B 209 1 14 HELIX 17 17 LYS B 234 SER B 238 5 5 HELIX 18 18 LEU B 239 VAL B 260 1 22 HELIX 19 19 ILE B 261 ASP B 266 1 6 HELIX 20 20 PRO B 268 THR B 290 1 23 HELIX 21 21 GLN B 317 LEU B 320 5 4 HELIX 22 22 GLU B 321 LEU B 333 1 13 HELIX 23 23 HIS B 336 PHE B 349 1 14 HELIX 24 24 GLN B 358 CYS B 379 1 22 HELIX 25 25 GLN B 383 ARG B 387 5 5 HELIX 26 26 PHE B 388 HIS B 418 1 31 HELIX 27 27 THR B 422 GLY B 430 1 9 HELIX 28 28 SER B 444 HIS B 449 1 6 HELIX 29 29 HIS B 449 GLU B 458 1 10 SHEET 1 A10 PHE A 292 ASN A 293 0 SHEET 2 A10 THR A 298 CYS A 301 -1 O THR A 298 N ASN A 293 SHEET 3 A10 LEU A 304 LEU A 308 -1 O TYR A 306 N TRP A 299 SHEET 4 A10 VAL A 211 ARG A 216 -1 N GLN A 214 O SER A 305 SHEET 5 A10 VAL A 222 LYS A 226 -1 O TYR A 225 N LEU A 213 SHEET 6 A10 VAL B 222 LYS B 226 -1 O VAL B 222 N LYS A 226 SHEET 7 A10 VAL B 211 ARG B 216 -1 N LEU B 215 O TRP B 223 SHEET 8 A10 LEU B 304 LEU B 308 -1 O CYS B 307 N SER B 212 SHEET 9 A10 THR B 298 CYS B 301 -1 N TRP B 299 O TYR B 306 SHEET 10 A10 PHE B 292 ASN B 293 -1 N ASN B 293 O THR B 298 CRYST1 85.240 89.240 105.230 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011732 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011206 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009503 0.00000